2024

March 3, 2025

Proposed issue of securities – AN1

March 3, 2025

FOS Capital – Anagenics Restructure

March 3, 2025

AN1 – Restructure Update

March 3, 2025

Results of Meeting

March 3, 2025

2024 AGM Presentation 261124

March 3, 2025

Final Director’s Interest Notice – Karen Matthews

March 3, 2025

Restructuring Update & Resignation of Director

March 3, 2025

Q1 F25 Activity Statement and Appendix 4C

March 3, 2025

Notice of Annual General Meeting/Proxy Form